대한방사선기술학회지:방사선기술과학 (Journal of radiological science and technology)

  • 제41권4호
  • /
  • Pages.313-319
  • /
  • 2018
  • /
  • 2288-3509(pISSN)
  • /
  • 2384-1168(eISSN)
대한방사선과학회 (Korean Society of Radiological Science)
권호 표지
DOI QR코드

DOI QR Code

대사증후군과 하부요로증상, PSA 및 전립샘 용적과의 연관성 : 단일기관 연구

Association between Metabolic Syndrome and Lower Urinary Tract Symptoms, Prostate Specific Antigen, and Prostate Volume: Single C enter Study

  • 투고 : 2018.07.17
  • 심사 : 2018.08.27
  • 발행 : 2018.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The purpose of this study was to investigate the influence of metabolic syndrome (MS) on the lower urinary tract symptoms (LUTS), prostate specific antigen (PSA), and prostate volume in Korean men. We analyzed the data from 2654 men over the age of 40 who visited our health promotion center for regular health checkups. Of the total 2654 men, mean age, PSA level, International Prostate Symptom Score (IPSS), and prostate volume were 54.6 years, 1.21ng/ml, 6.2 points, and 27.8ml, respectively. All examinees were divided into MS group (46.5%, 1235 men) and non-MS group (53.5%, 1419). Age and prostate volume were significantly higher in the MS group. The patients were divided into three groups according to their ages: 40's, 50's, and over 60 years old. Prostate volume of the MS group in the younger age groups (40-49 years and 50-59 years) was significantly larger than that of the non-MS group. However, no difference was revealed in the age group of 60-69 years. No significant differences were found in the PSA level and LUTS between the MS and non-MS groups. In the multivariate regression analysis, central obesity was the strongest risk factor for the enlargement of prostate over 30ml among the metabolic components.

키워드

참고문헌

  1. Kim YM, Yoon J, Byeon IK, Lee HM, Kim HG. Location Studies of Prostate Volume Measurement by using Transrectal Ultrasonography: Experimental Study by Self-Produced Prostate Phantom. Journal of Radiological Science and Technology 2015;38:437-42. https://doi.org/10.17946/JRST.2015.38.4.14
  2. Kim MY. The relationship between serum prostate specific antigen and prostate volume of measured by transrectal ultrasonography. Journal of Radiological Science and Technology 2010;33:239-43.
  3. Park HS, Park CY, Oh SW, Yoo HJ. Prevalence of obesity and metabolic syndrome in Korean adults. Obes Rev 2008;9:104-7.
  4. Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts? Circulation 2003;108: 1546-51. https://doi.org/10.1161/01.CIR.0000088846.10655.E0
  5. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9. https://doi.org/10.2337/diacare.24.4.683
  6. Gao Y, Wang M, Zhang H, Tan A, Yang X, Qin X, et al. Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey. Urology 2012;79:194-201. https://doi.org/10.1016/j.urology.2011.07.1399
  7. Lee RK, Chung D, Chughtai B, Te AE, Kaplan SA. Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms. BJU Int 2012;110:540-5. https://doi.org/10.1111/j.1464-410X.2011.10819.x
  8. Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001;39:151-8. https://doi.org/10.1159/000052430
  9. Hammarsten J, Hogstedt B, Holthuis N, Mellstrom D. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1998;1:157-62. https://doi.org/10.1038/sj.pcan.4500221
  10. Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H, Gokkaya S, Memis A. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol 2007;51:199-203; discussion 4-6. https://doi.org/10.1016/j.eururo.2006.05.040
  11. Parsons JK, Sarma AV, McVary K, Wei JT. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol 2009;182:S27-31. https://doi.org/10.1016/j.juro.2009.07.086
  12. Kim JH, Shim BS, Kim JS, Hong YS. Voiding Dysfunction of Men is Associated with Metabolic Syndrome. Korean J Urol AID - 10.4111/kju.2006.47.3.257 [doi] 2006;47:257-62.
  13. Kwon NS, Jo MK, Park K. The Relationship between the Metabolic Syndrome and the Risk of Benign Prostatic Hyperplasia: a Hospital-Based Study from a Health Screening Population. Korean J Urol AID - 10.4111/kju.2007.48.10.1016 [doi] 2007;48:1016-21.
  14. Hong GS, Shim BS, Chung WS, Yoon H. Correlation between Metabolic Syndrome and Lower Urinary Tract Symptoms of Males and Females in the Aspect of Gender-Specific Medicine: A Single Institutional Study. Korean J Urol 2010;51:631-5. https://doi.org/10.4111/kju.2010.51.9.631
  15. Jeong JH, Kim ET, Kim DK. Association of metabolic syndrome and benign prostate enlargement in young korean males. Korean J Urol 2011;52:757-62. https://doi.org/10.4111/kju.2011.52.11.757
  16. Park JS, Park JK. The Meaning of Metabolic Syndrome X in Patients Suffering with Benign Prostatic Hyperplasia. Korean J Urol AID - 10.4111/kju.2007.48.7.696 [doi] 2007;48:696-700.
  17. Koo KC, Cho KS, Kang EM, Kwon SW, Hong SJ. The Relationship between Metabolic Syndrome and Prostate Volume in Men Over Sixties who Underwent Prostate Health Check-up. Korean J Urol AID - 10.4111/kju.2008.49.9.813 [doi] 2008;49:813-7.
  18. Park HK, Lee HW, Lee KS, Byun SS, Jeong SJ, Hong SK, et al. Relationship between lower urinary tract symptoms and metabolic syndrome in a community-based elderly population. Urology 2008;72:556-60. https://doi.org/10.1016/j.urology.2008.03.043
  19. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421. https://doi.org/10.1161/circ.106.25.3143
  20. Lee SH, Chung BH, Kim CS, Lee HM, Kim CI, Yoo TK, et al. Survey on benign prostatic hyperplasia distribution and treatment patterns for men with lower urinary tract symptoms visiting urologists at general hospitals in Korea: a prospective, noncontrolled, observational cohort study. Urology 2012;79:1379-84. https://doi.org/10.1016/j.urology.2012.02.010
  21. Lee S, Min HG, Choi SH, Kim YJ, Oh SW, Kim YJ, et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity (Silver Spring) 2006;14:172-9. https://doi.org/10.1038/oby.2006.21